__MAIN_TEXT__

Page 1

Media Information 2019


The Mighty Clinical Research Industry

Our contribution to the Industry

Clinical Research Industry has grown around the world in an unparalled rate in the past few years. The global pharmaceutical market is estimated at US$ 427 billion, and research and development cost is estimated at US$ 60 – 65 billion annually. Two thirds of this amount is spent on drug development, i.e. approximately US$ 40 billion. Clinical trials involve almost 70% of time and money of new drug development. Cost of conducting clinical trials for a new drug is approximately US$ 200 – 250 million.

Pharmaceutical Industries vision to bring cure for all, need to bring medicines to market faster, and the intention to make healthcare available to all has seen trials being conducted in many locations. The access to patients with varied gene pool, food and cultural habits and population exposed to specific diseases has seen regions like India, China, Africa, Middle East and Latin America become major sites for sponsor companies to conduct their clinical trials. As with all global operations, operating under different regulatory guidelines, understanding different cultural and ethical values and finding the right partners, has remained a challenge for pharmaceutical, bio – pharmaceutical and medical device companies.

Why Choose JCS Key Facts about JCS 91% of advertisers have repeated advertisements in JCS every year. 88.4% of JCS readers are involved in the decision of purchasing products & services for their Company.

JCS with its distinguished editorial advisory board provides you with the best practice guidelines for conducting global clinical trials. We are the specialist journal providing you with relevant articles which will help you to navigate emerging markets.

82% of JCS subscribers read or look through the journal within one week of receiving their copy. 81% of advertisers have advertised in every consecutive year. 16% of impact factor makes JCS a journal of choice for both academia and the industry.

Influential Decision Makers


Circulation & Readership In Print

In Digital

JCS is a globally distributed publication with an established presence across the world. Each Bi-monthly issue has a print copy distribution figure of 24,200 copies, and digital distribution figure of 17,300, providing strong access to the International Market. JCS is sent directly to key decision makers in the Clinical Research Industry.

Readership By Job Function

JCS – Journal for Clinical Studies E Blast - provides the latest business news, product news, events, technical papers, and links to company information and services. This gives you the regular and latest update on products and services offered to the global clinical trials industry. JCS eBlast - is sent to more than 17,345 professionals working for the leading pharmaceutical companies, midsized bio technology companies, clinical research organisations, other vendors & service providers, and government & non-government agencies.

14%

Corporate Management (Medical Directors / Medical Affairs)

14%

Research and Development (Project Management)

12%

Heads of Clinical Trials

39%

Mid Sized Biotechnology Companies

10%

Heads of IT (Date Management / Analysis / Biostatistics)

26%

Big Pharma

24%

CRO's

11%

Other Stakeholders

7%

Heads of Lifesciences

7%

Logistics and Supply Chain Managers

7%

Regulatory Affairs / Compliance / Drug Safety / Pharmacovigilance

6%

Clinical research Coordinator (CRC / Study Coordinator / Research Nurse)

6%

Clinical Research Associate (CRA Monitor)

6%

GCP Auditing / OC / QA

6%

Laboratory Analysis

5%

Contracting / Procurement Officers

Industry Breakdown

Recipients By Job Functions 15%

Medical Directors / Medical Affairs

12%

Heads of Clinical Trials

10%

Regulatory Affairs

8%

Study Coordinator / Research Nurse

6%

IT / Data Management / Biostatistics

3%

Contract / Procurement

Geographical Distribution USA Print: Digital:

8,442 6,282 ROW Print: Digital:

3,387 1,350

Print: Digital:

EUROPE 8,474 7,395

Print: Digital:

ASIA 3,969 3,590


Rates & Data Print Media

Digital Media

Print Advertisement

Website Banner Advertisement

Double Page Full Page Half Page (Vertical / Horizontal)

£ 5,250 £ 2,850

Home Page Popup 640 x 480 px

Rate: £2,500 for 3 months

£ 1,650

Corner Peel Specs sent upon request

Rate: £1,800 for 3 months

Leader Board 728 x 90 px

Rate: £1,000 for 3 months

Right Column Rectangular 300 x 250 px

Rate: £900 per 3 months

Right Column Skyscraper 300 x 600 px

Rate: £900 per 3 months

Left Column Skyscraper 300 x 600 px

Rate: £800 for 3 months

Left Column Rectangular 300 x 250 px

Rate: £600 per 3 months

Host Videos

Rate: £600 for 3 months

Sponsored Articles

Rate: £400 per 3 months

Events Listing

Rate: £150 for 3 months

News:

Rate: £150 for 3 months

Prime Positions: Inside Front Cover Inside Back Cover Outside Back Cover Page Opposite Contents Page Opposite Editor’s Letter 1 Page Corporate Profile Front Cover LOGO

£ 5,950 £ 4,850 £ 7,250 £ 3,750 £ 3,750 £ 2,000 £ 1,500

Discounts apply for series bookings. Inserts, reprints and recruitment advertisers’ rates are available on application. For more information contact: sales@ipimedia.com

Mechanical Specifications (In mm, Height x Width, with Type, Trim, Bleed) Type Full Page: 273 x 186

Trim 297 x 210

Bleed 303 x 213

½ Pages: 135 x 186 (Horizontal)

148 x 210

151 x 213

½ Pages: (Vertical)

297 x 105

273 x 92

303 x 108

Please supply digitally, ideally a press ready PDF. Alternatively supply as a flat image file (Tiff, Jpeg, EPS, PSD etc) ensuring that all fonts are embedded, images are High-resolution and the file is CMYK

E Blast & E Newsletter Campaign JCS holds a secured database of over 17,345 professionals working for the leading pharmaceutical, midsized bio technology companies, CRO's and other stakeholders, who have given their consent to receive a Weekly Electronic Newsletter and any 3rd part relevant supplier information. JCS provides a direct communication link to these high net worth individuals through its Electronic Campaign Platforms.

E Newsletter:

E Blast: HTML E Blast:

Rate: £100 Per Week (Minimum of 4 weeks booking) Rate: £1,387 Per Campaign


JCS - Digital Media Information

jforcs.com

Average E Blast CTR: 2.8 Average E Newsletter CTR: 2.6

jforcs.com is an online portal providing readers with peer reviewed articles from industry experts, news bulletins, company directory and technical white papers. Website visitors are also able to access the entire archive of JCS articles. The location report from Google analytics (2017/2018 ) reveals that over 92% of visits came from Europe, America, Asia and Middle East. The leading countries are United States, United Kingdom, Germany, France, Norway, Switzerland, Italy, China, India, UAE, Saudi Arabia and Australia.

Total amount of Impressions in 2018

17216472 Total amount of clicks in 2018:

52326

White Papers Jforcs.com presents technical white papers, highlighting each contributing organisation's expertise and knowledge within its fields. White papers appear on the site in an accessible, searchable archive, which can be easily viewed and downloaded by readers.

Total amount of unique Impressions in 2018:

14127125 Total amount of unique clicks in 2018:

41231 twitter.com/jforcsjournal facebook.com/Journal-for-Clinical-Studies

plus.google.com/+jforcsjournal

jforcs.tumblr.com/

Digital Journal and eNewsletter The digital magazine edition of JCS is a fully interactive, page turning version of the print magazine. The e-Journal is emailed to a growing list of digital subscribers in a regular newsletter, expanding JCS's print circulation to a broad international readership.

Company Capabilities Jforcs.com's online company profile listings provides a guide for readers wishing to find out more about service providers. The company listings features company contact information, along with 800 word description, company logo and website links.


JCS - Editorial Calendar 2019 JCS – Journal for Clinical Studies is peer reviewed. Supported by a team of industry experts, JCS brings you contemporary and authoritative articles which will guide the industry in the best practice in regulatory issues, market analysis, drug discovery, development, drug design, clinical research, data analysis, safety and efficacy, recruitment and retention, laboratories, analytical testing, custom and contract manufacturing, primary and secondary packaging and logistics and supply chain management. This Editorial Calendar is a Guideline only. It is subject to change according to the movements in the industry. If you are interested in featuring a specific article within JCS, please email your suggestion along with a short 100 word synopsis to the editor at: editorial@jfrcs.com

Editorial Sections include but are not limited to: Watch Pages

Regulatory Guidelines

Market Report

Therapeutics

Clinical & Medical Research

Analytical Testing

Clinical Trials Supply

Manufacturing & Packaging

Central Labs & Core Labs

Recruitment & Retention

Laboratories

Innovations

Data Management

Investment & Finance

Market EntryProtocol Peer Review Criteria for Publication Provides strong evidence for its conclusions. • Novel • Unbiased • Non Promotional. Of extreme importance to stakeholders in the Pharmaceutical Industry. In general, to be acceptable, a paper should represent an advance in understanding likely to influence thinking in the field. There should be a good and clear reason why the work deserves the visibility of publication in a Pharma Publications journal rather than a different journal.

Author Guidelines A typical article will be about 2000 - 2500 words. You can include from 4 - 5 images, graphs or graphics with the article. The article must be sent to us in a Word Document format, and all associate images should be supplied separately in a High Resolution (PDF, Jpeg, PNG) file. [300 dpi minimum]. Article Title: Should not be more that 10 words in length. Author Bios: Author Bios should not be more that 60 words in length. Please also supply us with Author Email. Author Picture(s): Please send Author(s) Headshots in High Resolution (300dpi minimum), (Jpeg, PDF format) Please visit our website @ jforcs.com, or request from our editorial team the entire Peer Review Protocol, and the Author Guidelines.


Volume 11 Issue 1 Editorial Submission Deadline:

Issue Date: 25th January 2019 10th December 2019

Watch Pages Bite sized editorial on topics governing the clinical research Industry. From 700 words to 1500 word features on a particular issue. Companies & Individual wishing to contribute within the Watch Pages of JCS must commit to at least 6 issues. For Further information please write to: editorial@jfrcs.com Typical Watch Pages preferred are: FDA/EMA Regulations, Regulatory updates in emerging countries, Cardiovascular Safety, Rare Disease, Oncology Studies, Logistics etc.

Market Reports

Other Features:

Country Focus

Avoiding hidden costs in conducting clinical trials

Singapore

Japan

Thailand

China

South Korea

Malaysia

Site Selection Pharmacovigilance & Risk Management Clinical Trials Reimbursement

Clinical & Medical Research Guiding the clinical trials industry in digital health – dissecting digital health data collection methodologies Strategic alignment of study objectives and endpoints to drive value and fill data gaps The increasing inclusion of biomarkers as an eligible criterion for participation in clinical trials Assessing complexity of study design and matching to systems based on efficiency and costeffectiveness

Therapeutics Market Entry

Clinical Trials Materials Management

CNS Disease Focus on: Alzheimer's / Dementia

Clinical Trials Packaging & Labelling

Cardiovascular / Metabolic

Multi-tenant cloud platform to mange, track and report clinical trial activities

Obesity & Metabolic

Improvements Through ERP

Technology

Logistics & Supply Chain

Big Data and AI initiatives changing the competitive landscape

Clinical Trials Logistics

The `beyond the pill` model: apps and wearable devices The electronic laboratory notebooks : addressing data security and privacy concerns Using advanced analytics and languageprocessing capabilities to deliver clinical decision support

The security of patient data in digital supply chains RFID and NFC Tags The blockchain promise Subsection: Cardiovascular Safety


Volume 11 Issue 2 Editorial Submission Deadline:

Issue Date: 25th March 2019 10th February 2019

Watch Pages Bite sized editorial on topics governing the clinical research Industry. From 700 words to 1500 word features on a particular issue. Companies & Individual wishing to contribute within the Watch Pages of JCS must commit to at least 6 issues. For Further information please write to: editorial@jfrcs.com Typical Watch Pages preferred are: FDA/EMA Regulations, Regulatory updates in emerging countries, Cardiovascular Safety, Rare Disease, Oncology Studies, Logistics etc.

Market Reports

Other Features:

Country Focus

Imaging Labs / Central Labs/ECG & Core Labs

USA

Canada

Latin America

Late Stage Research (II - IV) Patient Recruitment & Retention Mergers & Acquisitions

Clinical & Medical Research Patient centricity in support of clinical operations and study adherence What does Brexit mean for clinical trials applications? The importance of Subject Recruitment and Retention to clinical trial success Unique challenges and opportunities in orphan diseases Outsourcing and collaborative research in clinical trials

Therapeutics Market Entry

Clinical Trials Materials Management

Food Borne

Clinical Trials Packaging & Labelling

Bacterial & Mycotic Ophthalmology

Multi-tenant cloud platform to mange, track and report clinical trial activities

Diabetes

Improvements Through ERP

Technology

Logistics & Supply Chain

EDC - Data Capture & Evaluation

Building a patient-centric supply chain

The rise of virtual drug design tools

Integrating cybersecurity solutions

Virtual screening and database building

Supply chain meets blockchain innovation

Scientific apps in the labs The 3D printed pill technology

Subsectioncontrol – innovative solutions Temperature Advancements in GPS tracking options GDP requirements: the understanding and application of Quality Risk Management (QRM)


Volume 11 Issue 3 Editorial Submission Deadline:

Issue Date: 25th May 2019 10th April 2019

Watch Pages Bite sized editorial on topics governing the clinical research Industry. From 700 words to 1500 word features on a particular issue. Companies & Individual wishing to contribute within the Watch Pages of JCS must commit to at least 6 issues. For Further information please write to: editorial@jfrcs.com Typical Watch Pages preferred are: FDA/EMA Regulations, Regulatory updates in emerging countries, Cardiovascular Safety, Rare Disease, Oncology Studies, Logistics etc.

Market Reports

Other Features:

Country Focus

Early Phase (I & II)

Sub Saharan Africa

South Africa

Middle East & North Africa

Remote Data Acquisition & Analysis Medical Writing Translation Services

Clinical & Medical Research Application challenges of the new EU Clinical Trial Regulation Planning a global trial to gather study data faster to obtain a quick approval Future perspectives and innovations in clinical studies High throughput screening, databases and proprietary algorithms Q & A on FDA` Post-marketing safety surveillance program for drug and therapeutic biologic products

Therapeutics Market Entry

Clinical Trials Materials Management

Rare Disease

Comparator Drug Supply

Infectious Diseases

Named Patient Programmes

Oncology Vaccine Development

Assessing of study design and matching to systems based on efficiency & cost.

Technology

Logistics & Supply Chain

ePRO, BOYD, eCOA, eCTD

New approaches in pharma logistics

CDISC / CDASH

Securing the Pharma Supply chain: the current challenges

Data Management & Biometrics

Sourcing and procurement

Subsection

Optimisation and cost management Subsection: Early Phase Trials

Logistics control in extreme weather conditions


Volume 11 Issue 4 Editorial Submission Deadline:

Issue Date: 25th July 2019 10th June 2019

Watch Pages Bite sized editorial on topics governing the clinical research Industry. From 700 words to 1500 word features on a particular issue. Companies & Individual wishing to contribute within the Watch Pages of JCS must commit to at least 6 issues. For Further information please write to: editorial@jfrcs.com Typical Watch Pages preferred are: FDA/EMA Regulations, Regulatory updates in emerging countries, Cardiovascular Safety, Rare Disease, Oncology Studies, Logistics etc.

Market Reports

Other Features:

Country Focus

The new EU clinical trials regulations

Russia

CEE States

CIS States

Central Europe

Use of Investigative sites in Central & Eastern Europe. RIB & Ethics Review Board The Sunshine Act

Clinical & Medical Research Evaluating needs and available in-house resources for managing data and regulatory documentation. Pharmacogenomics & Personalised Medicine Biomarkers & Biosimilars Study oversight models and quality / risk management systems

Therapeutics Market Entry

Clinical Trials Materials Management

Rare Disease

Building Effective Teams in the Clinical Trial Schematic

Infectious Diseases Oncology Vaccine Development

Supply and storage Investigational labelling and packa

Technology

Logistics & Supply Chain

EDC - Data Capture & Evaluation

Sample management

The rise of virtual drug design tools

Sourcing and Procurement

Virtual screening and database building Scientific apps in the labs The 3D printed pill technology

Optimisation and Cost Management

Subsection

Subsection: Data Management


Volume 11 Issue 5 Editorial Submission Deadline:

Issue Date: 25th September 2019 10th August 2019

Watch Pages Bite sized editorial on topics governing the clinical research Industry. From 700 words to 1500 word features on a particular issue. Companies & Individual wishing to contribute within the Watch Pages of JCS must commit to at least 6 issues. For Further information please write to: editorial@jfrcs.com Typical Watch Pages preferred are: FDA/EMA Regulations, Regulatory updates in emerging countries, Cardiovascular Safety, Rare Disease, Oncology Studies, Logistics etc.

Market Reports

Other Features:

Country Focus

Globalising Clinical Trials

UK

EU

Scandinavia

The promise of reporting system in patient safety Emerging role of bioinformatics tools in the evolution of clinical research Medical Writing

Clinical & Medical Research Medical Device & Trials Increasing the Industry Sustaiability by using patient inspired solutions Artificial Intelligence in Clinical & Medical Research Bioprinting and cancer research AI based tools in drug discovery

Therapeutics Market Entry

Clinical Trials Materials Management

CNS

Comparator Drug Supply

Focus on: Schizophrenia / Depression

Named Patient Programmes

Reproductive & Maternal Health

Assessing of study design and matching to systems based on efficiency & cost.

Pediatric

Technology

Logistics & Supply Chain

e Clinical Technologies

Sample management

Translation Services

Sourcing and Procurement

IVRS/IWRS

Subsection: Late Phase Trials

Optimisation and Cost Management

Subsection


Volume 11 Issue 6 Editorial Submission Deadline:

Issue Date: 25th November 2019 10th October 2019

Watch Pages Bite sized editorial on topics governing the clinical research Industry. From 700 words to 1500 word features on a particular issue. Companies & Individual wishing to contribute within the Watch Pages of JCS must commit to at least 6 issues. For Further information please write to: editorial@jfrcs.com Typical Watch Pages preferred are: FDA/EMA Regulations, Regulatory updates in emerging countries, Cardiovascular Safety, Rare Disease, Oncology Studies, Logistics etc.

Market Reports

Other Features:

Country Focus

Risk Based Monitoring

Australia & New Zealand

FSP versus full service

India

Clinical Trials Insurance

China

Global Outsourcing and vendor management

Clinical & Medical Research Guiding the Clinical Trials Industry in Digital Health. Strategic alignment of study objectives and endpoints to drive value and fill data gaps The increasing inclusion of biomarkers as an eligible criterion for participation in clinical trials. Responsibilities of the sponsor and the monitor

Therapeutics Market Entry

Clinical Trials Materials Management

Paediatrics

Randomization and blinding

Oncology in Paediatrics

Handling of and accountability for pharmaceutical products for trial

Obesity Respiratory (COPD)

Termination of trial - Returns & Destruction

Technology

Logistics & Supply Chain

Monitoring, Auditing and Inspection

Monitoring market-specific requirements

Record-keeping and handling of data

Multinational logistics service networks

Information for subjects and informed consent Adverse event reporting

instruction for Compliant Submissions Subsection offered in US & Europe


Contact: International Pharmaceutical Industry 50 D - The City Business Centre St Olav's Court London – SE16 2XB United Kingdom T: +44 (0) 207 2372036 E: info@jfrcs.com W: www.jforcs.com Advertising Contact: Charles Donovan charles@jfrcs.com Editorial: Freya Gavaghan freya@jfrcs.com Production: Virginia Toteva virginia@jfrcs.com Subscriptions: Martin Wright martin@jfrcs.com

Profile for Pharma Publications

JCS - Journal for Clinical Studies  

JCS - Journal for Clinical Studies  

Profile for mark123